RE:Q2 2020 Resultsand they still have approx. $7 million of non-dilutive funding to draw on between the DoD (Department of Defence) MTEC award and the interest free loan from WD (Economic Diversification Canada).
..Although the Company had previously planned to seek regulatory approval for its DispersinB® human wound care hydrogel as a medical device under the 510(k) pathway, the Company is currently reviewing other strategies based on market analysis provided by its consultants as well as preliminary feedback recently received from the FDA. The Company is now evaluating a number of pathways in order to determine which pathway will ultimately be more lucrative by allowing for claims and a higher price point. Kane is also conducting this review to better leverage the approximately $7 million in remaining WD and DoD non-dilutive funding that is available for this program. https://www.sedar.com/GetFile.do?lang=EN&docClass=7&issuerNo=00018973&issuerType=03&projectNo=03104624&docId=4788258 As well as new pet products and milestones coming in remaining 2020 there should be the human market dandruff shampoo mid 4th Q
Kane has also developed a scalp detoxifier, shampoo and shampoo bar using our patented coactiv+ technology. The products are formulated to break down bacterial and fungal biofilms as well as the accumulation of precipitated shampoo films, helping to support the reduction of skin irritation and other symptoms associated with chronic skin conditions. The detoxifier recently passed a Human Repeat Insult Patch Test (HRIPT) safety test allowing us to add the claims “Dermatologically tested” and “Safe for skin” to our packaging. After an overwhelmingly positive response from an initial consumer trial recently conducted in Canada, an extensive Phase 2 consumer trial is scheduled to start early Q4 2020 in both Canada and the United States, and Kane is poised to officially launch the products under the DermaKB Biofilm brand on our own eCommerce site by mid-Q4 2020
Kanes Management Discussions on Sedar for Aug 27th 2020 is a very good read.
I am impressed with this company . Such a relief to many that produce fluff and excusses. This very well managed and focused company with some major steps into the human market for 2020.